New User!
Register
0 items in cart $0.00

Research

What Is Otosclerosis?

Florical and Monocal

MCGUIRT WT AND OTHERS. LINKAGE OF A GENE FOR OTOSCLEROSIS TO CHROMOSOME 15Q25-Q26 AND IDENTIFICATION OF A CANDIDATE GENE: AGGRECAN. AROABSTRACTS, #428, 1998.

NADOL JB. OTOSCLEROSIS: CLINICAL ASPECTS AND MANAGEMENT. AUDIO-DIGEST OTOLARYNGOLOGY 31,#2, JAN 15, 1998

SHAMBAUGH GE JR. FLUORIDE THERAPY FOR OTOSCLEROSIS.ARCH OTOLARYNGOL HEAD NECK SURG 1990 OCT;116(10):1217

THERAPY OF ESTABLISHED POSTMENOPAUSAL OSTEOPOROSIS WITH MONOFLUOROPHOSPHATE PLUS CALCIUM

DOSE-RELATED EFFECTS ON BONE DENSITY AND FRACTURE RATE

J. D. RINGE, C. KIPSHOVEN, A. COSTER AND R. UMBACH

DEPARTMENT OF INTERNAL MEDICINE 4, KLINIKUNI LEVERKUSEN, LEVERKUSEN, GERMANY

ARE ANTIRESORPTIVE AGENTS THE ULTIMATE

THERAPY FOR OSTEOPOROSIS?

P.D. DELMAS INSERM RESEARCH UNIT 403 AND CLAUDE BERNARD UNIVERSITY OF LYON, FRANCE

NEW EVIDENCEFOR THE FRACTURE–REDUCING EFFECTIVENESS OF MONOFLUOROPHOSPHATE: PRACTICAL IMPLICATIONS

BONE AND CARTILAGE METABOLISM UNIT UNIVERSITY OF LIEGE BELGIUM-DEPARTMENT OF EPIDEMIOLOGY PUBLIC HEALTH, LIEGE BELGIUM-GEORGETOWN UNIVERSITY MEDICAL

CENTER,WASHINGTON, D.C

Intermittent or Continuous Treatment with Monofluorophosphate alone in the combination with Antiresorptive: Current data and perspectives.

J.D. Ringe Dept. Of Internal Medicine 4, Klinikum Leverkusen,

University of Cologne, Germany

Biotinidase Deficiency:A Booklet for Families and Professionals

By Deborah L. Thibodeau, M.S. and Barry Wolf, M.D., Ph.

WHAT IS OSTEOPOROSIS?